Acronym LumpFISH
Category
Aquaculture
Title The cleanerfish lumpfish (Cyclopterus lumpus L.)- Immunity, diseases and health Programme National Programme
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source National Coordinator Gyri Teien Haugland Coordinator email NA
Coordinator institution
UiB - University of Bergen (Norway)
Institutions involved
NA - Fjord Forsk Sogn AS (Norway) ,
IMR - Institute of Marine Research (Norway) ,
NINA - Norwegian Institute for Nature Research (Norway) ,
NVI - Norwegian Veterinary Institute (Norway) ,
NA - PHARMAQ AS (Norway) ,
USC - University of Santiago de Compostela (Spain) ,
UoS - University of Stirling (United Kingdom) ,
Start year 2015 End year 2019 Funding (€) € 2,105,263 Website https://prosjektbanken.forskningsradet.no/en/project/FORISS/244148?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=30&ProgAkt.3=HAVBRUKS-Havbruk%20-%20en%20n%C3%A6ring%20i%20vekst Summary "Lumpfish is used as cleaner fish to remove lice from Atlantic salmon. As the supply of lumpfish is based strictly on farmed individuals, it is a sustainable, environmental friendly and gentle alternative to medical and mechanical treatment. In recent years, the demand for lumpfish has led to an increase in the production from around 0.4 million lumpfish in 2012 to 30 million in 2018. In parallel with increased used of cleaner-fish and the rapid increase in number of lumpfish produced, health-related challenges emerged. Large scale disease outbreaks among the lumpfish, caused by Pasteurella-like bacteria, Vibrio and atypical Aeromonas salmonicida affected fish-welfare and reduced the overall efficiency of the cleaner-fish strategy.
In the current project, we have focused on immunity, infections and preventive health measures of lumpfish. The goals have been to expand our knowledge of how lumpfish respond upon infections and stimulations, and to develop vaccines protecting the lumpfish against its pathogens. Although progress regarding more efficient vaccines has been made, more work is needed to optimize and develop vaccines tailored for lumpfish. We have characterized immune cells and immune responses in lumpfish by doing RNA sequencing and whole transcriptome analyses as well as in-depth analyses of selected immune molecules. Furthermore, we have developed anaesthetic protocols for lumpfish, developed protocols for pharmacokinetic analyses of plasma and different tissues of lumpfish and evaluated the effect of different antibacterial treatment of lumpfish after experimental challenge with Vibrio anguillarum, atypical Aeromonas salmonicida and Pasteurella sp. Also, we have done pathogenicity testing of different bacteria by used of an in vitro multi-well method. Our goal is that the results generated from the project will contribute to improve fish health and good ethical conditions both under production and during its use as cleaner-fish."
Keywords
Lump fish;
Bacteria;
Fish;
Fish health;
Vaccines development;
Antibacterial;
Genomic;
Disease;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
